Literature DB >> 1413995

Baculovirus expression of the glycoprotein gene of Lassa virus and characterization of the recombinant protein.

K B Hummel1, M L Martin, D D Auperin.   

Abstract

A recombinant baculovirus was constructed that expresses the glycoprotein gene of Lassa virus (Josiah strain) under the transcriptional control of the polyhedrin promoter. The expressed protein (B-LSGPC) comigrated with the authentic viral glycoprotein as observed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), was reactive with monoclonal antibodies (MAbs) in Western blots, and was glycosylated. Although the recombinant protein was not processed into the mature glycoproteins, G1 and G2, it demonstrated reactivity with all known epitopes as measured by indirect immunofluorescence (IFA), and it was immunogenic, eliciting antisera in rabbits that recognized whole virus in IFAs. Regarding future applications to diagnostic assays, the recombinant glycoprotein proved to be an effective substitute for Lassa virus-infected mammalian cells in IFAs and it was able to distinguish sera from several human cases of Lassa fever, against a panel of known negative sera of African origin, in an enzyme immunoassay (EIA).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1413995     DOI: 10.1016/0168-1702(92)90101-e

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  5 in total

1.  Detection of Lassa virus antinucleoprotein immunoglobulin G (IgG) and IgM antibodies by a simple recombinant immunoblot assay for field use.

Authors:  J Ter Meulen; K Koulemou; T Wittekindt; K Windisch; S Strigl; S Conde; H Schmitz
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

2.  Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever.

Authors:  Masayuki Saijo; Marie-Claude Georges-Courbot; Philippe Marianneau; Victor Romanowski; Shuetsu Fukushi; Tetsuya Mizutani; Alain-Jean Georges; Takeshi Kurata; Ichiro Kurane; Shigeru Morikawa
Journal:  Clin Vaccine Immunol       Date:  2007-07-18

3.  Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever.

Authors:  Luis M Branco; Jessica N Grove; Frederick J Geske; Matt L Boisen; Ivana J Muncy; Susan A Magliato; Lee A Henderson; Randal J Schoepp; Kathleen A Cashman; Lisa E Hensley; Robert F Garry
Journal:  Virol J       Date:  2010-10-20       Impact factor: 4.099

Review 4.  Pathogenesis of Lassa fever.

Authors:  Nadezhda E Yun; David H Walker
Journal:  Viruses       Date:  2012-10-09       Impact factor: 5.048

Review 5.  Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development.

Authors:  Hoai J Hallam; Steven Hallam; Sergio E Rodriguez; Alan D T Barrett; David W C Beasley; Arlene Chua; Thomas G Ksiazek; Gregg N Milligan; Vaseeharan Sathiyamoorthy; Lisa M Reece
Journal:  NPJ Vaccines       Date:  2018-03-20       Impact factor: 7.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.